<DOC>
	<DOCNO>NCT00227097</DOCNO>
	<brief_summary>The objective project `` Educ'Avk '' , document efficacy strategy combine specific follow up-notebook education attend patient pedagogic support , comparatively usual education impact clinical event three month ( minor major hemorrhagic event + recurrence thrombi-embolic 's disease ) .</brief_summary>
	<brief_title>Educ'Avk : Recommendations Antivitamin K 's Gestion</brief_title>
	<detailed_description>Standard strategy implementation recommendation exclusively focus practitioner . But often appear effective ( insufficient time accord per patient , lack training… ) . However qualitative survey show benefit great role part patient process transmit recommendation practitioner . In study , patient education begin angiologist pharmacy student responsibility hospital investigator . Follow-up realize patient ’ general practitioner . More patient involvement realization recommendation could increase proportion practitioner follow recommendation decrease iatrogenicity antivitamin K ( AVK ) .</detailed_description>
	<mesh_term>Antivitamins K</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Able receive benefit sanitary educational act Able follow three month Acute episode venous 's thrombi embolic illness ( venous 's thrombosis distal proximal deep and/or lung embolism ) A.V.K . treatment period least three month Return residence ( included return retreat residence medicalize ) Informed consent form sign Distal venous thrombosis limit muscular vein without lung embolism Contraindication A.V.K . treatment Difficult comprehension french language Trouble visual acuity Trouble superior function incompatible educational 's act sanitary Psychosocial instability incompatible regular followup three month ( without fix residence , addictive lapse ) Impossibility return residence ( return retreat residence medicalize consider return residence ) Psychiatric pathology compensate Life expectancy less three month Refusal participation study Participation another clinical study Anterior inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>therapeutic education</keyword>
	<keyword>thrombus embolic disease</keyword>
</DOC>